<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04453215</url>
  </required_header>
  <id_info>
    <org_study_id>1298</org_study_id>
    <nct_id>NCT04453215</nct_id>
  </id_info>
  <brief_title>Dental Implant Therapy for Patients With Systemic Lupus Erythematosus</brief_title>
  <official_title>The Effect of Dental Implant Therapy for Patients With Systemic Lupus Erythematosus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Merve Benli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Istanbul University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Edentulous patients may be restored with conventional dentures, implant-supported
      overdentures or implant-supported fixed dental prostheses. Dental implants have been shown to
      alter the form of chewing muscles and oral function. However, systemic diseases such as
      systemic lupus erythematosus (SLE) may affect the results of dental implant treatment.
      Therefore, dental implant therapy has been evaluated in patients with SLE.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 12, 2019</start_date>
  <completion_date type="Actual">March 15, 2020</completion_date>
  <primary_completion_date type="Actual">December 23, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>volume of muscles</measure>
    <time_frame>1 week</time_frame>
    <description>The volume of the selected muscles will be recorded for comparison. With this aim, form of the chewing muscles will be evaluated by using the formula for muscle volume. Then, results will be compared within groups.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">86</enrollment>
  <condition>Systemic Lupus Erythematosus</condition>
  <condition>Dental Implant Failed</condition>
  <arm_group>
    <arm_group_label>mild group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with mild systemic lupus erythematosus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>moderate group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with moderate systemic lupus erythematosus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>severe group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients with severe systemic lupus erythematosus</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>dental implant</intervention_name>
    <description>Dental implant placement</description>
    <arm_group_label>mild group</arm_group_label>
    <arm_group_label>moderate group</arm_group_label>
    <arm_group_label>severe group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Edentulism

          -  Having systemic lupus erythematosus

        Exclusion Criteria:

          -  Having concurrent systemic diseases

          -  Using antimalarial drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Istanbul university,Faculty of Dentistry</name>
      <address>
        <city>Fatih</city>
        <zip>34452</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>June 28, 2020</study_first_submitted>
  <study_first_submitted_qc>June 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 1, 2020</study_first_posted>
  <last_update_submitted>June 30, 2020</last_update_submitted>
  <last_update_submitted_qc>June 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Istanbul University</investigator_affiliation>
    <investigator_full_name>Dr. Merve Benli</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

